De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival.

Source:http://linkedlifedata.com/resource/pubmed/id/17493011

Download in:

View as

General Info

PMID
17493011